More

    Europe Markets

    Icandra (previously Vildagliptin / metformin hydrochloride Novartis)

    OverviewIcandra is a diabetes medicine that is used together with diet and exercise to control the blood glucose (sugar) in adults with type...
    Europe Markets

    Stivarga | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Stivarga. It explains how the Agency assessed the medicine to recommend...
    Europe Markets

    Kesimpta | European Medicines Agency (EMA)

    OverviewKesimpta is a medicine for treating adults with relapsing forms of multiple sclerosis (MS), where the patient has flare-ups (relapses) followed by periods...
    Europe Markets

    EMA Open Door Day | European Medicines Agency (EMA)

    Event summary As part of the celebrations of...
    Europe Markets

    Tevimbra | European Medicines Agency (EMA)

    OverviewNon-small cell lung cancerTevimbra is used to treat non-small cell lung cancer (NSCLC) that is advanced or has spread to other parts of...
    Europe Markets

    Jaypirca | European Medicines Agency (EMA)

    OverviewJaypirca is a cancer medicine used to treat adults with mantle cell lymphoma (a cancer of B cells, a type of white blood...
    Europe Markets

    Eurneffy | European Medicines Agency (EMA)

    OverviewEurneffy is a medicine used for the emergency treatment of allergic reactions (anaphylaxis) caused by insect stings or bites, foods, medicines and other allergens...
    Europe Markets

    Quviviq | European Medicines Agency (EMA)

    OverviewQuviviq is a medicine for treating adults with insomnia (difficulty sleeping) that has lasted for at least 3 months and has a considerable...
    Europe Markets

    Vumerity | European Medicines Agency (EMA)

    OverviewVumerity is a medicine used to treat adults with a type of multiple sclerosis (MS) known as relapsing-remitting MS. MS is a disease...
    Europe Markets

    Apidra | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP)...
    Europe Markets

    Lantus | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Lantus. It explains how the Committee for Medicinal Products for Human...
    Europe Markets

    Emtricitabine/Tenofovir disoproxil Krka d.d. | European Medicines Agency (EMA)

    OverviewEmtricitabine/Tenofovir disoproxil Krka d.d. is an HIV medicine that is used in combination with at least one other HIV medicine to treat adults...
    Europe Markets

    Rapamune | European Medicines Agency (EMA)

    OverviewRapamune is a medicine used to prevent the body from rejecting a newly transplanted kidney. It is used in adults who are at...
    Europe Markets

    Alkindi | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Alkindi. It explains how the Agency assessed the medicine to recommend...
    Europe Markets

    Cejemly | European Medicines Agency (EMA)

    OverviewCejemly is a cancer medicine used in adults to treat a lung cancer called non-small cell lung cancer (NSCLC) that has spread to...
    Europe Markets

    Hepcludex | European Medicines Agency (EMA)

    OverviewHepcludex is an antiviral medicine used to treat chronic (long-term) hepatitis delta virus (HDV) infection in adults and children from 3 years of...
    Europe Markets
    1...101112...16Page 11 of 16

    © 2025 Liberte